Pyridoxalated haemoglobin polyoxyethylene

Drug Profile

Pyridoxalated haemoglobin polyoxyethylene

Alternative Names: Hemoximer; PHP; PHP-CT; PHP-HT; PHP-OC; Pyridoxalated haemoglobin polyethylene; VTR-PHP

Latest Information Update: 16 Oct 2012

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ajinomoto
  • Developer Curacyte Inc
  • Class Haemoglobins; Polyethylene glycols
  • Mechanism of Action Nitric oxide inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cardiogenic shock

Highest Development Phases

  • Discontinued Rheumatoid arthritis; Septic shock; Shock

Most Recent Events

  • 26 Aug 2011 Discontinued - Phase-II for Shock in USA (IV)
  • 26 Aug 2011 Discontinued - Phase-III for Septic shock in European Union (IV)
  • 03 Feb 2011 Pyridoxalated haemoglobin polyoxyethylene is still in phase III trials for Septic shock in the European Union
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top